Advanced in Epidermolytic Hyperkeratosis

Ulrike Peytavi-Blume

Charité Universitätsmedizin
Berlin, BE, DE 
Advanced in Epidermolytic Hyperkeratosis
Charité Universitätsmedizin
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Ulrike Peytavi-Blume practices in Berlin, Germany. Ms. Peytavi-Blume is rated as an Advanced expert by MediFind in the treatment of Epidermolytic Hyperkeratosis. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Alopecia Areata, Intertrigo, Acne, and Hormone Replacement Therapy (HRT).

Her clinical research consists of co-authoring 279 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Epidermolytic Hyperkeratosis.

Gender
Female

Locations

Charité Universitätsmedizin
Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Effect of Calcipotriol Plus Betamethasone Dipropionate Gel on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to 16 Years, 11 Months) With Scalp and Body Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 mo of Age) With Mild to Moderate Plaque Psoriasis
A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 mo of Age) With Mild to Moderate Plaque Psoriasis
Enrollment Status: Completed
Publish Date: February 18, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

279 Total Publications

Carcinoma en Cuirasse Revealing Urothelial Carcinoma Recurrence.
Carcinoma en Cuirasse Revealing Urothelial Carcinoma Recurrence.
Journal: International journal of dermatology
Published: June 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Peytavi-Blume's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 34 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile